A
Anne Flint
Researcher at Novo Nordisk
Publications - 63
Citations - 8496
Anne Flint is an academic researcher from Novo Nordisk. The author has contributed to research in topics: Appetite & Semaglutide. The author has an hindex of 35, co-authored 63 publications receiving 7577 citations. Previous affiliations of Anne Flint include University of Copenhagen.
Papers
More filters
Journal ArticleDOI
Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies.
TL;DR: VAS scores are reliable for appetite research and do not seem to be influenced by prior diet standardization, however, consideration should be given to the specific parameters being measured, their sensitivity and study power.
Journal ArticleDOI
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
TL;DR: The results show that GLP-1 enhanced satiety and reduced energy intake and thus may play a physiological regulatory role in controlling appetite and energy intake in humans.
Journal ArticleDOI
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans.
Camilla Verdich,Anne Flint,Jean-Pierre Gutzwiller,Erik Näslund,Christoph Beglinger,Per M. Hellström,S. J. Long,Linda M. Morgan,Jens J. Holst,Arne Astrup +9 more
TL;DR: The aim was to examine the effect of glucagon-like peptide-1 on subsequent energy intake using a data set composed of subject data from previous studies and from two as yet unpublished studies, and investigate whether the effect on energy intake is dose dependent and differs between lean and overweight subjects.
Journal ArticleDOI
Meals with similar energy densities but rich in protein, fat, carbohydrate, or alcohol have different effects on energy expenditure and substrate metabolism but not on appetite and energy intake
TL;DR: The data do not support the proposed relation between the macronutrient oxidation hierarchy and the satiety hierarchy, and despite differences in substrate metabolism and hormone concentrations, satiety and ad libitum energy intake were not significantly different between meals.
Journal ArticleDOI
Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults
TL;DR: Liraglutide-induced weight loss appears to be mediated by reduced appetite and energy intake rather than increased EE, and a relative shift toward increased fat and reduced carbohydrate oxidation was observed with liragLutide.